FEBRUARY 2022
latest news.
Cosette Pharmaceuticals Launches First Injectable Product – Prochlorperazine Edisylate Injection in the U.S.
Launch Further Diversifies Cosette’s Product Offerings In-Line with Growth Strategy
us.
Together, everyone at Cosette contributes to a culture that fosters innovation, celebrates collaboration and recognizes excellence. We are in a perpetual pursuit of having the highest quality standards, the most efficient supply chain and innovate every day in everything we do.
leadership.
Our highly experienced leadership team is busy writing the next, most ambitious chapter of our story. Building on a 100+ year heritage, their shared vision of innovation will leverage our expertise, efficiency, and infrastructure to create remarkable new opportunities.
products.
While staying true to our proud therapeutic history of dermatology products, suppositories, and oral liquids, we’re busy expanding our offerings – through strategic partnerships and internal R&D. Our focus on innovation and supply reliability is the foundation of our rapidly diversifying portfolio.
newsroom.
Cosette Pharmaceuticals Acquires Rights to Eight Branded Products from Daiichi Sankyo
Transformational Transaction Diversifies Cosette’s Business to Accelerate Future Growth BRIDGEWATER, NJ – JANUARY 18, 2022: Cosette [...]
Mindy Hanna has joined Cosette Pharmaceuticals as Senior Director, Human Resources
We are pleased to announce Mindy Hanna has joined Cosette Pharmaceuticals as Senior Director, Human [...]
Solaris Pharma Receives Approval for First Generic Version of Clindagel® (clindamycin phosphate EQ 1%)
BRIDGEWATER, N.J., Aug. 23, 2021 (GLOBE NEWSWIRE) -- Solaris Pharma Corporation (“Solaris” or the “Company”) [...]